Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 3Neoplasms 3Lymphoma 3Leukemia 3Infections 3Lymphoma, Non-Hodgkin 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Febrile Neutropenia 1Cystectomy 1Colorectal Neoplasms 1Agammaglobulinemia 1

Interventions

plerixafor 1gamma-Globulins 1Trimethoprim, Sulfamethoxazole Drug Combination 1Saline Solution 1Immunoglobulins 1Hizentra 1Clavulanic Acid 1Ciprofloxacin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Agammaglobulinemia × Ciprofloxacin × Clear all
NCT05678621 2024-04-19

RATIONALISE

Monash University

Phase 2/3 Recruiting
300 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Agammaglobulinemia, Infections, Leukemia, Lymphoma, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡